Chapter 9 Interaction of Polyene Macrolide Antibiotics with Lipid Model Membranes

Advances in Planar Lipid Bilayers and Liposomes

Volumn 3, Issue , 2006, Pages 269-329

  Baginski, Maciej ^a   Cybulska, Barbara ^a,c   Gruszecki, Wieslaw I ^b  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^c Elblag University of Humanities and Economy   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA; STREPTOMYCES;

EID: 34249279237     PISSN: 15544516     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1554-4516(05)03009-7     Document Type: Review

References (331)

1. Hazen E.L., and Brown R. Fungicidin, an antibiotic produced by a soil actinomycete. Proc. Soc. Exptl. Biol. Med. 76 (1951) 93-97
2. Worthen D.R., Jay M., and Bummer P.M. Methods for the recovery and purification of polyene antifungals. Drug Dev. Ind. Pharm. 27 (2001) 277-286
3. Omura S., and Tanaka H. Production, structure, and antifungal activity of polyene macrolides. In: Omura S. (Ed). Macrolide Antibiotics (1984), Academic Press, Orlando 351-404
4. Gale E.F. Mode of action and resistance mechanisms of polyene macrolides. In: Omura S. (Ed). Macrolide Antibiotics (1984), Academic Press, Orlando 425-455
5. Schaffner C.P. Polyene macrolides in clinical practice: pharmacology and adverse and other effects. In: Omura S. (Ed). Macrolide Antibiotics (1984), Academic Press, Orlando 457-507
6. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties?. Biochim. Biophys. Acta 864 (1986) 257-304
7. Kerridge D. Mode of action of clinically important antifungal drugs. Adv. Microb. Physiol. 27 (1986) 1-72
8. Joly V., Bolard J., and Yeni P. In vitro model for studying toxicity of antifungal agents. Antimicrob. Agents Chemother. 36 (1992) 1799-1804
9. Zotchev S.B. Polyene macrolide antibiotics and their applications in human therapy. Curr. Med. Chem. 10 (2003) 211-223
10. Ellis D. Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother. 49 (2002) 7-10
11. T.M. Sternberg, E.T. Wright, M. Oura, A new antifungal antibiotic, amphotericin B, Antibiot. Ann. (1956) 566-573.
12. W. Gold, H.A. Stout, J.F. Pagano, R. Donovick, Amphotericins A and B, antifungal antibiotics produced by a Streptomycete. I. In vitro studies, Antibiot. Ann. (1956) 579-585.
13. Brajtburg J., Powderly W.G., Kobayashi G.S., and Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrob. Agents Chemother. 34 (1990) 183-188
14. Gallis H.A., Drew R.H., and Pickard W.W. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12 (1990) 308-329
15. Warnock D.W. Amphotericin B: an introduction. J. Antimicrob. Chemother. 28 Suppl. B (1991) 27-38
16. Hartsel S.C., Hatch C., and Ayenew W. How does amphotericin B work? Studies on model membrane systems. J. Liposome Res. 3 (1993) 377-408
17. Hartsel S., and Bolard J. Amphotericin B: new life for an old drug. Trends Pharmacol. Sci. 17 (1996) 445-449
18. Gottlieb D., Carter H.E., Sloneker J.H., and Ammann A. Protection of fungi against polyene antibiotics by sterols. Science 128 (1958) 361
19. Lampen J.O. Interference by polyenic antifungal antibiotics (especially nystatin and filipin) with specific membrane functions. Symp. Soc. Gen. Microbiol. 16 (1966) 111-130
20. Andreoli T.E., Dennis V.W., and Weigl A.M. The effect of amphotericin B on the water and nonelectrolyte permeability of thin lipid membranes. J. Gen. Physiol. 53 (1969) 33-154
21. Holz R., and Finkelstein A. The water and nonelectrolyte permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B. J. Gen. Physiol. 125 (1970) 145
22. Archer D.B., and Gale E.F. Antagonism by sterols of the action of amphotericin and filipin on the release of potassium ions from Candida albicans and Mycoplasma mycoides subsp. capri. J. Gen. Microbiol. 90 (1975) 187-190
23. Medoff G., Brajtburg J., Kobayashi G.S., and Bolard J. Antifungal agents useful in therapy of systemic fungal infections. Annu. Rev. Pharmacol. Toxicol. 23 (1983) 303-330
24. Borowski E., and Cybulska B. Potassiumless death of Saccharomyces cerevisiae cells treated with N-succinyl perimicin and reversal of fungicidal action of the antibiotic by potassium ions. Nature 211 (1967) 1034-1035
25. Malewicz B., Jenkin H.M., and Borowski E. Repair of membrane alterations induced in baby hamster kidney cells by polyene macrolide antibiotics. Antimicrob. Agents Chemother. 19 (1981) 238-247
26. Cybulska B., Mazerski J., Borowski E., and Gary-Bobo C.M. Haemolytic activity of aromatic heptaenes. A group of polyene macrolide antifungal antibiotics,. Biochem. Pharmacol. 33 (1984) 41-46
27. Cybulska B., Borowski E., and Gary-Bobo C.M. Relationship between ionophoric and haemolytic activities of perimicin A and vacidin A, two polyene macrolide antifungal antibiotics. Biochem. Pharmacol. 38 (1989) 1755-1762
28. + exchanger of BALB/c B lymphoid cell line, A20. Biochem. Pharmacol. 44 (1992) 539-545
29. Cohen B.E. Amphotericin B toxicity and lethality: a tale of two channels. Int. J. Pharm. 162 (1998) 95-106
30. Andreoli T.E. On the anatomy of amphotericin B-cholesterol pores in lipid bilayer membranes. Kidney Int. 4 (1973) 337-345
31. Finkelstein A., and Holz R. Aqueous pores created in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B. In: Eisenman G. (Ed). Membranes (1973), Marcel Dekker, New York 377-408
32. Hammilton-Miller J.M.T. Fungal sterols and the mode of action of the polyene antibiotics. Adv. Appl. Microbiol. 17 (1974) 109-134
33. Kotler-Brajtburg J., Price H.D., Medoff G., Schlessinger D., and Kobayashi G.S. Molecular basis for the selective toxicity of amphotericin B for yeast and filipin for animal cells. Antimicrob. Agents Chemother. 5 (1974) 377-382
34. Teerlink T., De Kruijff B., and Demel R.A. The action of pimaricin, etruscomycin and amphotericin B on liposomes with varying sterol content. Biochim. Biophys. Acta 599 (1980) 484-492
35. Bolard J., Legrand P., Heitz F., and Cybulska B. One-side action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry 30 (1991) 5707-5715
36. Szlinder-Richert J., Mazerski J., Cybulska B., Grzybowska J., and Borowski E. MFAME, N-methyl-N-d-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self-association and effects on red blood cells. Biochim. Biophys. Acta 1528 (2001) 15-24
37. Baginski M., Resat H., and Borowski E. Comparative molecular dynamics simulations of amphotericin B-cholesterol/ergosterol membrane channels. Biochim. Biophys. Acta 1567 (2002) 63-78
38. Neely M.N., and Ghannoum M.A. The exciting future of antifungal therapy. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 897-914
39. Maertens J.A., and Boogaerts M.A. Fungal cell wall inhibitors: emphasis on clinical aspects. Curr. Pharm. Design 6 (2000) 225-239
40. Tkacz J.S., and DiDomenico B. Antifungals: what's in the pipeline. Curr. Opin. Microbiol. 4 (2001) 540-545
41. Denning D.W. Echinocandins: a new class of antifungal. J. Antimicrob. Chemother. 49 (2002) 889-891
42. Grzybowska J., Sowinski P., Gumieniak J., Zieniawa T., and Borowski E. N-methyl-N-d-fructopyranosylamphotericin B methyl ester, new amphotericin B derivative of low toxicity. J. Antibiot. 50 (1997) 709-711
43. Borowski E. Novel approaches in the rational design of antifungal agents of low toxicity. Farmaco 55 (2000) 206-208
44. Adler-Moore J., and Proffitt R.T. AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. J. Antimicrob. Chemother. 49 (2002) 21-30
45. Dupont B. Overview of the lipid formulations of amphotericin B. J. Antimicrob. Chemother. 49 (2002) 31-36
46. Aparicio J.F., Caffrey P., Gil J.A., and Zotchev S.B. Polyene antibiotic biosynthesis gene clusters. Appl. Microbiol. Biotechnol. 61 (2003) 179-188
47. Mechlinski W., Schaffner C.P., Ganis P., and Avitabile G. Structure and absolute configuration of the polyene macrolide antibiotic amphotericin B. Tetrahedron Lett. 44 (1970) 3873-3876
48. Ganis P., Avitabile G., Mechlinski W., and Schaffner C.P. Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative. J. Am. Chem. Soc. 93 (1971) 4560-4564
49. Sowinski P., Gariboldi P., Pawlak J.K., and Borowski E. The structure of vacidin A, an aromatic heptaene macrolide antibiotic. II. Stereochemistry of the antibiotic,. J. Antibiot. 42 (1989) 1639-1642
50. Sowinski P., Pawlak J., Borowski E., and Gariboldi P. Stereostructure of rimocidin. J. Antibiot. 48 (1995) 1288-1291
51. Sowinski P., Pawlak J., Borowski E., and Gariboldi P. Stereostructure of gedamycin. Polish. J. Chem. 69 (1995) 213-217
52. Sowinski P., Bieszczad T., Pawlak J., and Borowski E. Stereostructure of amphotericin A. J. Antibiot. 49 (1996) 1232-1235
53. Rochet P., and Lancelin J.M. Revised H-1 and C-13 NMR assignments of the polyene antibiotic filipin III. Magn. Reson. Chem. 35 (1997) 538-542
54. Volpon L., and Lancelin J.M. Solution NMR structure of five representative glycosylated polyene macrolide antibiotics with a sterol-dependent antifungal activity. Eur. J. Biochem. 269 (2002) 4533-4541
55. Chong C.N., and Rickards R.W. Macrolide antibiotic studies. XVII. Cyclic hemiketal structures in nystatin, amphotericin B, pimaricin and lucensomycin. Tetrahedron Lett. 49 (1972) 5053-5056
56. Rinnert H., and Maigret B. Conformational analysis of amphotericin B. I. Isolated molecule. Biochem. Biophys. Res. Commun. 101 (1981) 853-860
57. Berges J., Caillet J., Langlet J., Gresh N., Herve M., and Gary-Bobo C.M. Conformational study of the polar head of the amphotericin B in the isolated state and in the presence of water molecules. Stud. Phys. Theoret. Chem. 71 (1990) 253-263
58. Meddeb S., Berges J., Caillet J., and Langlet J. Comparative theoretical study of the conformations of amphotericin methyl ester and amphotericin-B polar heads in the presence of water. Biochim. Biophys. Acta 1112 (1992) 266-272
59. Mazerski J., and Borowski E. Molecular dynamics of amphotericin B. I. Single molecule in vacuum and water,. Biophys. Chem. 54 (1995) 49-60
60. Baginski M., Gariboldi P., Bruni P., and Borowski E. Conformational analysis of amphotericin B. Biophys. Chem. 65 (1997) 91-100
61. Baginski M., Resat H., and McCammon J.A. Molecular properties of amphotericin B membrane channel: a molecular dynamics simulation. Mol. Pharmacol. 52 (1997) 560-570
62. Resat H., Sungur F.A., Baginski M., Borowski E., and Aviyente V. Conformational properties of amphotericin B amide derivatives - impact on selective toxicity. J. Comput. Aid. Mol. Design 14 (2000) 689-703
63. Kotler-Brajtburg J., Medoff G., Kobayashi G.S., Boggs S., Schlessinger D., Pandey R.C., and Rinehart K.L. Classification of polyene antibiotics according to chemical structure and biological effects. Antimicrob. Agents Chemother. 15 (1979) 716-722
64. Cybulska B., Ziminski T., Borowski E., and Gary-Bobo C.M. The influence of electric charge of aromatic heptaene macrolide antibiotics on their activity on biological and lipidic model membranes. Mol. Pharmacol. 24 (1983) 270-276
65. 31P-NMR study. Biochim. Biophys. Acta 980 (1989) 261-272
66. Mazerski J., Grzybowska J., and Borowski E. Influence of net charge on the aggregation and solubility behaviour of amphotericin B and its derivatives in aqueous media. Eur. Biophys. J. 18 (1990) 159-164
67. Cybulska B., Bolard J., Seksek O., Czerwinski A., and Borowski E. Identification of the structural elements of amphotericin B and other polyene macrolide antibiotics of the heptane group influencing the ionic selectivity of the permeability pathways formed in the red cell membrane. Biochim. Biophys. Acta 1240 (1995) 167-178
68. Cheron M., Cybulska B., Mazerski J., Grzybowska J., Czerwinski A., and Borowski E. Quantitative structure-activity relationships in amphotericin B derivatives. Biochem. Pharmacol. 37 (1988) 827-836
69. Etingov E.D., Kholodova G.V., and Karnaushkina A.I. Acid-base properties of amphotericin B. Antibiotiki 17 (1972) 296-305
70. Mechlinski W., and Schaffner C.P. Polyene macrolide derivatives. I. N-acylation and esterification reactions with amphotericin B,. J. Antibiot. 25 (1972) 256-258
71. Falkowski L., Jarzebski A., Stefanska B., Bylec E., and Borowski E. The synthesis of amides of polyene macrolide antibiotics. J. Antibiot. 33 (1980) 103-104
72. Schaffner C.P. Amphotericin B derivatives. In: Fromtling R.A. (Ed). Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents (1987), L.R. Prous Science Publishers, S.A., Barcelona 595-632
73. Stefanska B., Zielinski J., Borowski E., and Falkowski L. Enamine and amidine derivatives of polyene macrolide antibiotics. Acta Pol. Pharm. 45 (1988) 71-76
74. Czerwinski A., Zieniawa T., Borowski E., and Micossi L.G. Amphotericin B 2-morpholinoethylamide diaspartate, a new water soluble derivative of the antibiotic. Synthesis and biological properties. J. Antibiot. 43 (1990) 680-683
75. Czerwinski A., Konig W.A., Zieniawa T., Sowinski P., Sinnwell V., Milewski S., and Borowski E. New N-alkyl derivatives of amphotericin B. Synthesis and biological properties,. J. Antibiot. 44 (1991) 979-984
76. Yamaji N., Matsumori N., Matsuoka S., Oishi T., and Murata M. Amphotericin B dimers with bisamide linkage bearing powerful membrane-permeabilizing activity. Org. Lett. 4 (2002) 2087-2089
77. Mazerski J., Cybulska B., Bolard J., and Borowski E. Structural features determining the haemolytic activity of vacidin A derivatives. Drugs Exp. Clin. Res. 12 (1986) 627-633
78. Czerwinski A., Konig W.A., Sowinski P., and Borowski E. Amides of polyene macrolide aureofacin. Synthesis and biological properties. J. Antibiot. 40 (1987) 1023-1027
79. Bruzzese T., Rimaroli C., Bonabello A., Ferrari E., and Signorini M. Amide derivatives of partricin A with potent antifungal activity. Eur. J. Med. Chem. 31 (1996) 965-972
80. Taylor A.W., Costello B.J., Hunter P.A., Maclachlan W.S., and Shanks C.T. Synthesis and antifungal selectivity of new derivatives of amphotericin-B modified at the C-13 position. J. Antibiot. 46 (1993) 486-493
81. Maclachlan W.S., and Readshaw S.A. Stereoselective synthesis of 13-dehydroxy-(14S)-hydroxyamphotericin B methyl ester. Tetrahedron Lett. 36 (1995) 1735-1738
82. Driver M.J., Greenlees A.R., Maclachlan W.S., Macpherson D.T., and Taylor A.W. Synthesis of 16-decarboxy-16-hydroxymethyl amphotericin B - a novel antifungal agent. Tetrahedron Lett. 33 (1992) 4357-4360
83. Baginski M., and Borowski E. Distribution of electrostatic potential around amphotericin B and its membrane targets. Theochem. J. Mol. Struct. 389 (1997) 139-146
84. Gruda I., Nadeau P., Brajtburg J., and Medoff G. Application of differential spectra in the ultraviolet-visible region to study the formation of amphotericin B-sterol complexes. Biochim. Biophys. Acta 602 (1980) 260-268
85. Mazerski J., Bolard J., and Borowski E. Self-association of some polyene macrolide antibiotics in aqueous media. Biochim. Biophys. Acta 719 (1982) 11-17
86. Ernst C., Grange J., Rinnert H., Dupont G., and Lematre J. Structure of amphotericin B aggregates as reveled by UV and CD spectroscopies. Biopolymers 20 (1981) 1575-1588
87. Hemenger R.P., Kaplan T., and Gray L.J. Structure of amphotericin B aggregates based on calculations of optical spectra. Biopolymers 22 (1983) 911-918
88. Millie P., Langlet J., Berges J., Caillet J., and Demaret J.P. Self-association of amphotericin B in water. Theoretical energy and spectroscopy studies,. J. Phys. Chem. B 103 (1999) 10883-10891
89. Milhaud J., Ponsinet V., Takashi M., and Michels B. Interactions of the drug amphotericin B with phospholipid membranes containing or not ergosterol: new insight, into them role of ergosterol. Biochim. Biophys. Acta 1558 (2002) 95-108
90. Barwicz J., Gruszecki W.I., and Gruda I. Spontaneous organization of amphotericin-B in aqueous medium. J. Coll. Interfac. Sci. 158 (1993) 71-76
91. Gruszecki W.I., Gagos M., and Herec M. Dimers of polyene antibiotic amphotericin B detected by means of fluorescence spectroscopy: molecular organization in solution and in lipid membranes. J. Photochem. Photobiol. B - Biol. 69 (2003) 49-57
92. Balakrishnan A.R., and Easwaran K.R.K. CD and NMR studies on the aggregation of amphotericin-B in solution. Biochim. Biophys. Acta 1148 (1993) 269-277
93. Caillet J., Berges J., and Langlet J. Theoretical study of the self-association of amphotericin B. Biochim. Biophys. Acta 1240 (1995) 179-195
94. Rinnert H., Thirion C., Dupont G., and Lematre J. Structural studies on aqueous and hydroalcoholic solutions of polyene antibiotic: amphotericin B. Biopolymers 16 (1977) 2419-2427
95. Bolard J., Seigneurt M., and Boudet G. Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B. Biochim. Biophys. Acta 599 (1980) 280-293
96. Gruda I., and Dussault N. Effect of the aggregation state of amphotericin B on its interaction with ergosterol. Biochem. Cell Biol. 66 (1988) 177-183
97. Lamy-Freund M.T., Ferreira V.F.N., and Schreier S. Polydispersity of aggregates formed by the polyene antibiotic amphotericin B and deoxycholate. A spin label study. Biochim. Biophys. Acta 981 (1989) 207-212
98. Tancrede P., Barwicz J., Jutras S., and Gruda I. The effect of surfactants on the aggregation state of amphotericin B. Biochim. Biophys. Acta 1030 (1990) 289-295
99. Lamy-Freund M.T., Schreier S., Peitzsch R.M., and Reed W.F. Characterization and time dependence of amphotericin B: deoxycholate aggregation by quasielastic light scattering. J. Pharm. Sci. 80 (1991) 262-266
100. Barwicz J., Christian S., and Gruda I. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob. Agents Chemother. 36 (1992) 2310-2315
101. Brittain H.G. Circular dichroism studies of the self-association of amphotericin B. Chirality 6 (1994) 665-669
102. Mazerski J., and Borowski E. Molecular dynamics of amphotericin B. II. Dimer in water. Biophys. Chem. 57 (1996) 205-217
103. Shervani Z., Etori H., Taga K., Yoshida T., and Okabayashi H. Aggregation of polyene antibiotics as studied by electronic absorption and circular dichroism spectroscopies. Coll. Surfac. B - Biointerfac. 7 (1996) 31-38
104. Romanini D., Avalle G., Nerli B., and Pico G. Thermodynamic and spectroscopic features of the behavior of amphotericin B in aqueous medium. Biophys. Chem. 77 (1999) 69-77
105. Lambing H.E., Wolf B.D., and Hartsel S.C. Temperature effects on the aggregation state and activity of amphotericin-B. Biochim. Biophys. Acta 1152 (1993) 185-188
106. Gaboriau F., Cheron M., Leroy L., and Bolard J. Physico-chemical properties of the heat-induced 'superaggregates' of amphotericin B. Biophys. Chem. 66 (1997) 1-12
107. Barwicz J., and Tancrede P. The effect of aggregation state of amphotericin-B on its interactions with cholesterol- or ergosterol-containing phosphatidylcholine monolayers. Chem. Phys. Lipids 85 (1997) 145-155
108. Gaboriau F., Cheron M., Petit C., and Bolard J. Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index. Antimicrob. Agents Chemother. 41 (1997) 2345-2351
109. Saint Pierre Chazalet M., Thomas C., Dupeyrat M., and Gary-Bobo C.M. Amphotericin B-sterol complex formation and competition with egg phosphatidylcholine: a monolayer study. Biochim. Biophys. Acta 944 (1988) 477-486
110. Seoane J.R., Vila Romeu N., Minones J., Conde O., Dynarowicz-Latka P., and Casas M. The behaviour of amphotericin B monolayers at the air/water interface. Progr. Coll. Polym. Sci. 105 (1997) 173-179
111. Minones J., Carrera C., Dynarowicz-Latka P., Conde O., Seoane R., and Patino J.M.R. Orientational changes of amphotericin B in Langmuir monolayers observed by Brewster angle microscopy. Langmuir 17 (2001) 1477-1482
112. Gruszecki W.I., Gagos M., and Kernen P. Polyene antibiotic amphotericin B in monomolecular layers: spectrophotometric and scanning force microscopic analysis. FEBS Lett. 524 (2002) 92-96
113. Seoane R., Minones J., Conde O., Casas M., and Iribarnegaray E. Molecular organisation of amphotericin B at the air-water interface in the presence of sterols: a monolayer study. Biochim. Biophys. Acta 1375 (1998) 73-83
114. Saka Y., and Mita T. Interaction of amphotericin B with cholesterol in monolayers, aqueous solutions, and phospholipid bilayers. J. Biochem. Tokyo 123 (1998) 798-805
115. Seoane R., Minones J., Conde O., Iribarnegaray E., and Casas M. Interactions between amphotericin B and sterols in monolayers. Mixed films of amphotericin B-cholesterol,. Langmuir 15 (1999) 5567-5573
116. Seoane R., Minones J., Conde O., Casas M., and Iribarnegaray E. Interaction between amphotericin B and sterols in monolayers. Mixed films of ergosterol-amphotericin B. Langmuir 15 (1999) 3570-3573
117. Minones J., Conde O., Seoane R., and Dynarowicz-Latka P. Influence of a spreading method on the properties of amphotericin B-dipalmitoyl phosphatidic acid mixed films at the air/water interface. Langmuir 16 (2000) 5743-5748
118. Minones J., Minones J., Conde O., Patino J.M.R., and Dynarowicz-Latka P. Mixed monolayers of amphotericin B-dipalmitoyl phosphatidyl choline: study of complex formation. Langmuir 18 (2002) 2817-2827
119. Minones J., Conde O., Minones J., Patino J.M.R., and Seoane R. Amphotericin B-dipalmitoyl phosphatidyl glycerol interactions responsible for the reduced toxicity of liposomal formulations: a monolayer study. Langmuir 18 (2002) 8601-8608
120. Kol M.A., vanLaak A.N.C., Rijkers D.T.S., Killian J.A., deKroon A.I.P.M., and deKruijff B. Phospholipid flop induced by transmembrane peptides in model membranes is modulated by lipid composition. Biochemistry 42 (2003) 231-237
121. Minones J., Dynarowicz-Latka P., Conde O., Minones J., Iribarnegaray E., and Casas M. Interactions of amphotericin B with saturated and unsaturated phosphatidylcholines at the air/water interface. Coll. Surface B 29 (2003) 205-215
122. Bittman R., and Fischkoff S.A. Fluorescence studies of the binding of polyene antibiotics filipin III, amphotericin B, nystatin and lagosin to cholesterol. Proc. Natl. Acad. Sci. USA 69 (1972) 3795-3799
123. Castanho M.A., and Prieto M.J. Fluorescence study of the macrolide pentaene antibiotic filipin in aqueous solution and in a model system of membranes. Eur. J. Biochem. 207 (1992) 125-134
124. Petersen N.O. Intramolecular fluorescence energy transfer in nitrobenzoxadiazole derivatives of polyene antibiotics. Can. J. Chem. 63 (1985) 77-85
125. Petersen N.O., and Henshaw P.F. Separation of fluorescent impurities from amphotericin B. Can. J. Chem. 59 (1981) 3376-3378
126. Gruszecki W.I., and Herec M. Dimers of polyene antibiotic amphotericin B. J. Photochem. Photobiol. B - Biol. 72 (2003) 103-105
127. Gruszecki W.I., Gagos M., Herec M., and Kernen P. Organization of antibiotic amphotericin B in model lipid membranes. A mini review,. Cell. Mol. Biol. Lett. 8 (2003) 161-170
128. B.A. Steinberg, W.P. Jambor, L.O. Suydam, Amphotericin A and B: two new antifungal antibiotics possessing high activity against deep-seated and superficial mycoses, Antibiot. Ann. (1956) 574-578.
129. El On J., Messer G., and Greenblatt C.L. Growth inhibition of Leishmania tropica amastigotes in vitro by rifampicin combined with amphotericin B. Ann. Trop. Med. Parasitol. 78 (1984) 93-98
130. McColm A.A., and McHardy N. Evaluation of a range of antimicrobial agents against the parasitic protozoa, Plasmodium falciparum, Babesia rodhaini and Theileria parva in vitro. Ann. Trop. Med. Parasitol. 78 (1984) 345-354
131. Panosian C.B., Barza M., Szoka F., and Wyler D.J. Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B. Antimicrob. Agents Chemother. 25 (1984) 655-656
132. Dietze R., Milan E.P., Berman J.D., Grogl M., Falqueto A., Feitosa T.F., Luz K.G., Suassuna F.A.B., Marinho L.A.C., and Ksionski G. Treatment of Brazilian Kala-Azar with a short course of Amphocil (amphotericin-B cholesterol dispersion). Clin. Infect. Dis. 17 (1993) 981-986
133. Ramos H., Valdivieso E., Gamargo M., Dagger F., and Cohen B.E. Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions. J. Membrane Biol. 152 (1996) 65-75
134. Schaffner C.P., Plescia O.J., Pontani D., Sun D., Thornton A., Pandey R.C., and Sarin P.S. Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture. Biochem. Pharmacol. 35 (1986) 4110-4113
135. Pontani D.R., Sun D., Brown J.W., Shahied S.I., Plescia O.J., Schaffner C.P., Lopez Berestein G., and Sarin P.S. Inhibition of HIV replication by liposomal encapsulated amphotericin B. Antivir. Res. 11 (1989) 119-125
136. Pleskoff O., Seman M., and Alizon M. Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion. J. Virol. 69 (1995) 570-574
137. Konopka K., Guo L.S.S., and Duzgunes N. Anti-HIV activity of amphotericin B-cholesteryl sulfate colloidal dispersion in vitro. Antivir. Res. 42 (1999) 197-209
138. Pocchiari M., Schmittinger S., and Masullo C. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J. Gen. Virol. 68 (1987) 219-223
139. Xi Y.G., Ingrosso L., Ladogana A., Masullo C., and Pocchiari M. Amphotericin-B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 356 (1992) 598-601
140. Stanton R.V., Little L.R., and Merz K.M. Quantum free energy perturbation study within a PM3 MM coupled potential. J. Phys. Chem. 99 (1995) 483-486
141. Adjou K.T., Deslys J.P., Demaimay R., and Dormont D. Probing the dynamics of prion diseases with amphotericin B. Trends Microbiol. 5 (1997) 27-31
142. Hartsel S.C., and Weiland T.R. Amphotericin B binds to amyloid fibrils and delays their formation: a therapeutic mechanism?. Biochemistry 42 (2003) 6228-6233
143. Hauser W.E.J., and Remington J.S. Effect of amphotericin B on natural killer cell activity in vitro. J. Antimicrob. Chemother. 11 (1983) 257-262
144. Bistoni F., Vecchiarelli A., Mazzolla R., Puccetti P., Marconi P., and Garaci E. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans. Antimicrob. Agents Chemother. 27 (1985) 625-631
145. Little J.R., and Shore V. Modulation by lipoproteins of amphotericin B-induced immunostimulation. Cell Immunol. 93 (1985) 212-221
146. Wolf J.E., Stein S.H., Little K.D., Abegg A.L., and Little J.R. Amphotericin B selectively stimulates macrophages from high responder mouse strains. Immunopharmacol. Immunotoxicol. 13 (1991) 221-235
147. Carlson M.A., and Condon R.E. Nephrotoxicity of amphotericin B. J. Am. Coll. Surgeons 179 (1994) 361-381
148. Harbarth S., Pestotnik S.L., Lloyd J.F., Burke J.P., and Samore M.H. The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am. J. Med. 111 (2001) 528-534
149. Varlam D.E., Siddiq M.M., Parton L.A., and Russmann H. Apoptosis contributes to amphotericin B-induced nephrotoxicity. Antimicrob. Agents Chemother. 45 (2001) 679-685
150. Deray G. Amphotericin B nephrotoxicity. J. Antimicrob. Chemother. 49 (2002) 37-41
151. Maschmeyer G. New antifungal agents - treatment standards are beginning to grow old. J. Antimicrob. Chemother. 49 (2002) 239-241
152. Cheng J.T., Witty R.T., Robinson R.R., and Yarger W.E. Amphotericin B nephrotoxicity: increased renal resistance and tubule permeability. Kidney Int. 22 (1982) 626-633
153. Zager R.A., Bredl C.R., and Schimpf B.A. Direct amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents. Kidney Int. 41 (1992) 1588-1594
154. Barwicz J., Gareau R., Audet A., Morisset A., Villiard J., and Gruda I. Inhibition of the interaction between lipoproteins and amphotericin B by some delivery systems. Biochem. Biophys. Res. Commun. 181 (1991) 722-728
155. Wasan K.M., Rosenblum M.G., Cheung L., and Lopezberestein G. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B. Antimicrob. Agents Chemother. 38 (1994) 223-227
156. Hsu S.F., and Burnette R.R. Characterization of the effects of amphotericin B on ion channels in MDCK cells using the patch-clamp technique. Biochim. Biophys. Acta 1329 (1997) 26-38
157. Barwicz J., Dumont I., Ouellet C., and Gruda I. Amphotericin B toxicity as related to the formation of oxidatively modified low-density lipoproteins. Biospectroscopy 4 (1998) 135-144
158. Hartsel S.C., Baas B., Bauer E., Foree L.T., Kindt K., Preis H., Scott A., Kwong E.H., Ramaswamy M., and Wasan K.M. Heat-induced superaggregation of amphotericin B modifies its interaction with serum proteins and lipoproteins and stimulation of TNF-alpha. J. Pharm. Sci. 90 (2001) 124-133
159. Ellis W.G., Sobel R.A., and Nielsen S.L. Leukoencephalopathy in patients treated with amphotericin B methyl ester. J. Infect. Dis. 146 (1982) 125-137
160. Ellis W.G., Bencken E., LeCouteur R.A., Barbano J.R., Wolfe B.M., and Jennings M.B. Neurotoxicity of amphotericin B methyl ester in dogs. Toxicol. Pathol. 16 (1988) 1-9
161. Reuhl K.R., Vapiwala M., Ryzlak M.T., and Schaffner C.P. Comparative neurotoxicities of amphotericin-B and its mono-methyl ester derivative in rats. Antimicrob. Agents Chemother. 37 (1993) 419-428
162. Adler Moore J.P., and Proffitt R.T. Development, characterization, efficacy and mode of action of Abisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Res. 3 (1993) 429-450
163. Gulati M., Bajad S., Singh S., Ferdous A.J., and Singh M. Development of liposomal amphotericin B formulation. J. Microencapsul. 15 (1998) 137-151
164. Arikan S., and Rex J.H. Lipid-based antifungal agents: current status. Curr. Pharm. Design 7 (2001) 393-415
165. Walsh T.J., Finberg R.W., Arndt C., Hiemenz J., Schwartz C., Bodensteiner D., Pappas P.G., Seibel N., Greenberg R.N., Dummer S., Schuster S., and Holcenberg J.S. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. New Engl. J. Med. 340 (1999) 764-771
166. Ritter J. Amphotericin B and its lipid formulations. Mycoses 45 (2002) 34-38
167. OstroskyZeichner L., Marr K.A., Rex J.H., and Cohen S.H. Amphotericin B: time for a new "gold standard". Clin. Infect. Dis. 37 (2003) 415-425
168. Lavasanifar A., Samuel J., and Kwon G.S. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate l-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. J. Control. Release 77 (2001) 155-160
169. Lavasanifar A., Samuel J., Sattari S., and Kwon G.S. Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharmaceut. Res. 19 (2002) 418-422
170. Adams M.L., Andes D.R., and Kwon G.S. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(l-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. Biomacromolecules 4 (2003) 750-757
171. New R.R., Chance M.L., and Heath S. Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. J. Antimicrob. Chemother. 8 (1981) 371-381
172. Graybill J.R., Craven P.C., Taylor R.L., Williams D.M., and Magee W.E. Treatment of murine cryptococcosis with liposome-associated amphotericin B. J. Infect. Dis. 145 (1982) 748-752
173. Taylor R.L., Williams D.M., Craven P.C., Graybill J.R., Drutz D.J., and Magee W.E. Amphotericin B in liposomes: a novel therapy for histoplasmosis. Am. Rev. Respir. Dis. 125 (1982) 610-611
174. van Gool R. The cost of treating systemic fungal infections. Drugs 61 (2001) 49-56
175. Cass A., Finkelstein A., and Krespi V. The ion permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B. J. Gen. Physiol. 56 (1970) 100-145
176. Brajtburg J., Elberg S., Medoff J., Kobayashi G.S., Schlessinger D., and Medoff G. Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells. Antimicrob. Agents Chemother. 26 (1984) 892-897
177. Brajtburg J., Elberg S., Schwartz D.R., Vertut-Croquin A., Schlessinger D., Kobayashi G.S., and Medoff G. Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B. Antimicrob. Agents Chemother. 27 (1985) 172-176
178. Sokol Anderson M.L., Brajtburg J., and Medoff G. Amphotericin B-induced oxidative damage and killing of Candida albicans. J. Infect. Dis. 154 (1986) 76-83
179. De Kruijff B., and Demel R.A. Polyene antibiotic-sterol interactions in membranes of acholeplasma laidlawii cells and lecithin liposomes. III. Molecular structure of the polyene antibiotic-cholesterol complexes,. Biochim. Biophys. Acta 339 (1974) 57-70
180. Marty A., and Finkelstein A. Pores formed in lipid bilayer membranes by nystatin. Differences in its one-sided and two-sided action. J. Gen. Physiol. 65 (1975) 515-526
181. Van Hoogevest P., and De Kruijff B. Effect of amphotericin B on cholesterol-containing liposomes of egg phosphatidylcholine and didocosenoyl phosphatidylcholine. A refinement of the model for the formation of pores by amphotericin B in membranes. Biochim. Biophys. Acta 511 (1978) 397-407
182. Kleinberg M.E., and Finkelstein A. Single-length and double-length channels formed by nystatin in lipid bilayer membranes. J. Membrane Biol. 80 (1984) 257-269
183. Fujii G., Chang J.E., Coley T., and Steere B. The formation of amphotericin B ion channels in lipid bilayers. Biochemistry 36 (1997) 4959-4968
184. Khutorsky V.E., and Kamenchuk A.A. Molecular model for ionic permeability and selectivity of the amphotericin B channel. Biol. Membr. 5 (1988) 173-180
185. Khutorsky V.E., Kamenchuk A.A., and Ermishkin L.N. Computer analysis of amphotericin B channel structure. Biofizika 33 (1988) 794-799
186. Bonilla-Marin M., Moreno-Bello M., and Ortega-Blake I. A microscopic electrostatic model for the amphotericin B channel. Biochim. Biophys. Acta 1061 (1991) 65-77
187. Khutorsky V.E. Structures of amphotericin B-cholesterol complex. Biochim. Biophys. Acta 1108 (1992) 123-127
188. Golovanov I.B., and Tsygankova I.G. Simulation of an Amphotericin B channel. Membrane Cell Biol. 9 (1995) 335-346
189. Khutorsky V. Ion coordination in the amphotericin B channel. Biophys. J. 71 (1996) 2984-2995
190. Silberstein A. Conformational analysis of amphotericin B-cholesterol channel complex. J. Membrane Biol. 162 (1998) 117-126
191. Resat H., and Baginski M. Ion passage pathways and thermodynamics of the amphotericin B membrane channel. Eur. Biophys. J. Biophys. Lett. 31 (2002) 294-305
192. Borisova M.P., Brutyan R.A., and Ermishkin L.N. Mechanism of anion-cation selectivity of amphotericin B channels. J. Membrane Biol. 90 (1986) 13-20
193. - selectivity of the permeability pathways induced through sterol-containing membrane vesicles by amphotericin B and other polyene antibiotics. Eur. Biophys. J. 23 (1994) 125-132
194. Wolf B.D., and Hartsel S.C. Osmotic stress sensitizes sterol-free phospholipid bilayers to the action of amphotericin B. Biochim. Biophys. Acta 1238 (1995) 156-162
195. Cotero B.V., RebolledoAntunez S., and Ortega-Blake I. On the role of sterol in the formation of the amphotericin B channel. Biochim. Biophys. Acta 1375 (1998) 43-51
196. Ruckwardt T., Scott A., Scott J., Mikulecky P., and Hartsel S.C. Lipid and stress dependence of amphotericin B ion selective channels in sterol-free membranes. Biochim. Biophys. Acta 1372 (1998) 283-288
197. Venegas B., GonzalezDamian J., Celis H., and OrtegaBlake I. Amphotericin B channels in the bacterial membrane: role of sterol and temperature. Biophys. J. 85 (2003) 2323-2332
198. Weakliem C.L., Fujii G., Chang J.-E., Ben-Shaul A., and Gelbart W.M. Effect of tension on pore formation in drug-containing vesicles. J. Am. Chem. Soc. 99 (1995) 7694-7697
199. 2H-NMR. Biochim. Biophys. Acta 776 (1984) 317-329
200. Baginski M. Studies of selected molecular properties of amphotericin B and its cellular targets by theoretical chemistry methods - doctoral thesis (1995), Gdansk (Polish), Technical University of Gdansk
201. Baginski M., Tempczyk A., and Borowski E. Comparative conformational analysis of cholesterol and ergosterol by molecular mechanics. Eur. Biophys. J. 17 (1989) 159-166
202. Clejan S., and Bittman R. Rates of amphotericin B and filipin association with sterols. A study of changes in sterol structure and phospholipid composition of vesicles,. J. Biol. Chem. 260 (1985) 2884-2889
203. Baginski M., Bruni P., and Borowski E. Comparative analysis of the distribution of the molecular electrostatic potential for cholesterol and ergosterol. Theochem. J. Mol. Struct. 311 (1994) 285-296
204. Ghannoum M.A., and Rice L.B. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12 (1999) 501ff
205. Mickus D.E., Levitt D.G., and Rychnovsky S.D. Enantiomeric cholesterol as a probe of ion-channel structure. J. Am. Chem. Soc. 114 (1992) 359-360
206. Richter R.K., Mickus D.E., Rychnowski S.D., and Molinski T.F. Differential modulation of the antifungal activity of amphotericin B by natural and ent-cholesterol. Bioorg. Med. Chem. Lett. 14 (2004) 115-118
207. Singer S.J., and Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science 175 (1972) 720-731
208. Brown D. Structure and function of membrane rafts. Int. J. Med. Microbiol. 291 (2002) 433-437
209. Edidin M. The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32 (2003) 257-283
210. Bernsdorff C., and Winter R. Differential properties of the sterols cholesterol, ergosterol, beta-sitosterol, trans-7-dehydrocholesterol, stigmasterol and lanosterol on DPPC bilayer order. J. Phys. Chem. B 107 (2003) 10658-10664
211. Chapman D. Biological Membranes (1968), Academic Press, New York
212. Demel R.A., and DeKruyff B. The function of sterols in membranes. Biochim. Biophys. Acta 457 (1976) 109-132
213. Bloch K. Sterol structure and membrane function. Curr. Top. Cell. Regul. 18 (1981) 289-299
214. Oehlschlager A.C., and Laks P. Nitroxide spin-probe study of amphotericin B-ergosterol interaction in egg phosphatidylcholine multilayers. Can. J. Biochem. 58 (1980) 978-985
215. Paquet M.J., Fournier I., Barwicz J., Tancrede P., and Auger M. The effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers as viewed by H-2 NMR. Chem. Phys. Lipids 119 (2002) 1-11
216. In: Tien H.T., and Ottova-Leitmannova A. (Eds). Planar Lipid Bilayers (BLMs) and their Application (2003), Amsterdam, Elsevier
217. Rudenko S.V. Structural rearrangements induced by glycerol increase the permeability of bilayer lipid membranes for amphotericin (Russian). Biofizika 31 (1986) 59-63
218. Alekberli E.K., and Topaly V.P. Permeability of bilayer lipid membranes to amphotericin B (Russian). Biofizika 29 (1984) 322-323
219. Alekseev S.I., and Ziskin M.C. Millimeter microwave effect on ion transport across lipid bilayer membranes. Bioelectromagnetics 16 (1995) 124-131
220. Koufen P., Zeidler U., and Stark G. Photodynamic inactivation of ion channels formed by the polyene antibiotic amphotericin B in lipid membranes. J. Photochem. Photobiol. B - Biol. 38 (1997) 129-135
221. Gruszecki W.I., Zelent B., Tajmir-Riahi H.A., Wang G.M., Taleb T., Veeranjaneyulu K., and Leblanc R.M. Chlorophyll a-violaxanthin interactions in monolayers at air-water interface and in Langmuir-Blodgett films. Coll. Surfac. B - Biointerfac. 19 (2000) 117-125
222. Milanowska J., Polit A., Wasylewski Z., and Gruszecki W.I. Interaction of isomeric forms of xanthophyll pigment zeaxanthin with dipalmitoylphosphatidylcholine studied in monomolecular layers. J. Photochem. Photobiol. B - Biol. 72 (2003) 1-9
223. Niedzwiedzki D., and Gruszecki W.I. Interaction between chlorophyll a and violaxanthin in different steric conformations - model studies in monomolecular layers. Coll. Surfac. B - Biointerfac. 28 (2003) 27-38
224. Lance M.R., Washington C., and Davis S.S. Evidence for the formation of amphotericin B-phospholipid complexes in Langmuir monolayers. Pharmac. Res. 13 (1996) 1008-1014
225. Wojtowicz K., Gruszecki W.I., Walicka M., and Barwicz J. Effect of amphotericin B on dipalmitoylphosphatidylcholine membranes: calorimetry, ultrasound absorption and monolayer technique studies. Biochim. Biophys. Acta 1373 (1998) 220-226
226. Dynarowicz-Latka P., Seoane R., Minones J., Velo M., and Minones J. Study of penetration of amphotericin B into cholesterol or ergosterol containing dipalmitoyl phosphatidylcholine Langmuir monolayers. Coll. Surface B 27 (2003) 249-263
227. ReyGomezSerranillos I., Dynarowicz-Latka P., Minones J., and Seoane R. Desorption of amphotericin B from mixed monolayers with cholesterol at the air/water interface. J. Coll. Interfac. Sci. 234 (2001) 351-355
228. Kasha M. Energy transfer mechanisms and the molecular excitation model for molecular aggregates. Radiat. Res. 20 (1963) 55-71
229. Kasha M., Rawls H.R., and Ashraf El-Bayoumi M. The excitation model in molecular spectroscopy. Pure Appl. Chem. 11 (1965) 371-392
230. Parkash J., Robblee J.H., Agnew J., Gibbs E., Collings P., Pasternack R.F., and de Paula J.C. Depolarized resonance light scattering by porphyrin and chlorophyll a aggregates. Biophys. J. 74 (1998) 2089-2099
231. Bangham A.D., Standish M.M., and Watkins J.C. Diffusion of univalent ions across the lamelle of swollen phospholipids. J. Mol. Biol. 13 (1965) 238-252
232. Huang C. Studies on phosphatidylcholine vesicles. Formation and physical characteristics,. Biochemistry 8 (1969) 344-352
233. Szoka F.J., and Papahadjopoulos D. Comparative properties and methods of preparation of lipid vesicles. Annu. Rev. Biophys. Bioeng. 9 (1980) 467-508
234. Bolard J., and Milhaud J. Interaction of the anti-candida amphotericin B (and other polyene antibiotics) with lipids. In: Prasad R., and Ghannoum M.A. (Eds). Lipids of Pathogenic Fungi (1996), CRC Press, New York 253-274
235. Coutinho A., and Prieto M. Cooperative partition model of nystatin interaction with phospholipid vesicles. Biophys. J. 84 (2003) 3061-3078
236. Madden T.D., Janoff A.S., and Cullis P.R. Incorporation of amphotericin B into large unilamellar vesicles composed of phosphatidylcholine and phosphatidylglycerol. Chem. Phys. Lipids 52 (1990) 189-198
237. Janoff A.S., Boni L.T., Popescu M.C., Minchey S.R., Cullis P.R., Madden T.D., Taraschi T., Gruner S.M., Shyamsunder E., Tate M.W., Mendelsohn R., and Bonner D. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc. Natl. Acad. Sci. USA 85 (1988) 6122-6126
238. Perkins W.R., Minchey S.R., Boni L.T., Swenson C.E., Popescu M.C., Pasternack R.F., and Janoff A.S. Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. Biochim. Biophys. Acta 1107 (1992) 271-282
239. Rojanapanthu P., Sarisuta N., Chaturon K., and Kraisintu K. Physicochemical properties of amphotericin B liposomes prepared by reverse-phase evaporation method. Drug Develop. Ind. Pharm. 29 (2003) 31-37
240. Milhaud J., and Michels B. Binding of nystatin and amphotericin B with sterol-free l-dilauroylphosphatidylcholine bilayers resulting in the formation of dichroic lipid superstructures. Chem. Phys. Lipids 101 (1999) 223-235
241. Witzke N.M., and Bittman R. Dissociation kinetics and equilibrium binding properties of polyene antibiotic complexes with phosphatidylcholine/sterol vesicles. Biochemistry 23 (1984) 1668-1674
242. Bolard J., Vertut-Croquin A., Cybulska B., and Gary-Bobo C.M. Transfer of the polyene antibiotic amphotericin B between single-walled vesicles of dipalmitoylphosphatidylcholine and egg-yolk phosphatidylcholine. Biochim. Biophys. Acta 647 (1981) 241-248
243. Fournier I., Barwicz J., and Tancrede P. The structuring effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers: a differential scanning calorimetry study. Biochim. Biophys. Acta 1373 (1998) 76-86
244. Jullien S., Vertut-Croquin A., Brajtburg J., and Bolard J. Circular dichroism for the determination of amphotericin B binding to liposomes. Anal. Biochem. 172 (1988) 197-202
245. Milhaud J., Berrehar J., Lancelin J.M., Michels B., Raffard G., and Dufourc E.J. Association of polyene antibiotics with sterol-free lipid membranes. 2. Hydrophobic binding of nystatin to dilauroylphosphatidylcholine bilayers,. Biochim. Biophys. Acta 1326 (1997) 54-66
246. Legrand P., Cheron M., Leroy L., and Bolard J. Release of amphotericin B from delivery systems and its action against fungal and mammalian cells. J. Drug Target. 4 (1997) 311-319
247. Strom R., Blumberg W.E., Dale R.E., and Crifo C. The interaction of the polyene antibiotic lucensomycin with cholesterol in erythrocyte membranes and in model systems. Biophys. J. 16 (1976) 1297-1314
248. Loura L.M.S., Castanho A.R.B., Fedorov A., and Prieto M. A photophysical study of the polyene antibiotic filipin self-aggregation and filipin-ergosterol interaction. Biochim. Biophys. Acta 1510 (2001) 125-135
249. Petersen N.O., Gratton R., and Pisters E.M. Fluorescence properties of polyene antibiotics in phospholipid bilayer membranes. Can. J. Chem. 65 (1987) 238-244
250. Coutinho A., and Prieto M. Self-association of the polyene antibiotic nystatin in dipalmitoylphosphatidylcholine vesicles: a time-resolved fluorescence study. Biophys. J. 69 (1995) 2541-2557
251. Petersen N.O. A new fluorescent derivative of amphotericin B: synthesis, characterization and application in fluorescence photobleaching. Spectrosc. Int. J. 2 (1983) 408-414
252. O'Neil L.J., Miller J.G., and Petersen N.O. Evidence for nystatin micelles in L-cell membranes from fluorescence photobleaching measurements of diffusion. Biochemistry 25 (1986) 177-181
253. Henry Toulme N., Seman M., and Bolard J. Interaction of amphotericin B and its N-fructosyl derivative with murine thymocytes: a comparative study using fluorescent membrane probes. Biochim. Biophys. Acta 982 (1989) 245-252
254. Strauss G. The interaction of amphotericin B with lipid bilayer vesicles: determination of binding constants by absorption and fluorescence spectroscopy. Can. J. Spectrosc. 26 (1981) 95-102
255. Hamilton K.S., Barber K.R., Davis J.H., Neil K., and Grant C.W. Phase behaviour of amphotericin B multilamellar vesicles. Biochim. Biophys. Acta 1062 (1991) 220-226
256. Milhaud J., Lancelin J.M., Michels B., and Blume A. Association of polyene antibiotics with sterol-free lipid membranes: I. Hydrophobic binding of filipin to dimyristoylphosphatidylcholine bilayers,. Biochim. Biophys. Acta 1278 (1996) 223-232
257. 2H-NMR, circular dichroism. electronic absorption and fluorescence, Eur. Biophys. J. 17 (1989) 151-158
258. 2H NMR evidence for antibiotic-induced cholesterol immobilization in biological model membranes. Biochemistry 24 (1985) 2420-2424
259. Milhaud J., Mazerski J., and Bolard J. Competition between cholesterol and phospholipids for binding to phospholipids. Biochim. Biophys. Acta 987 (1989) 193-198
260. 2H-NMR. Biochim. Biophys. Acta 778 (1984) 435-442
261. Whyte B.S., Peterson R.P., and Hartsel S.C. Amphotericin B and nystatin show different activities on sterol-free vesicles. Biochem. Biophys. Res. Commun. 164 (1989) 609-614
262. Milhaud J. Permeabilizing action of filipin III on model membranes through a filipin-phospholipid binding. Biochim. Biophys. Acta 1105 (1992) 307-318
263. 2+ ionophore in sterol-containing liposomes. Biochim. Biophys. Acta 982 (1989) 303-306
264. 31P-NMR. Eur. Biophys. J. 12 (1985) 121-128
265. 31P-NMR. Mol. Pharmacol. 29 (1986) 293-298
266. Matsuoka S., and Murata M. Cholesterol markedly reduces ion permeability induced by membrane-bound amphotericin B. Biochim. Biophys. Acta 1564 (2002) 429-434
267. Aracava Y., Schreier S., Phadke R., Deslauriers R., and Smith I.C.P. Effects of amphotericin B on membrane permeability-kinetics of spin probe reduction. Biophys. Chem. 14 (1981) 325-332
268. - currents in phospholipid vesicles by amphotericin B. Biochemistry 27 (1988) 2656-2660
269. Cohen B.E. A sequential mechanism for the formation of aqueous channels by amphotericin B in liposomes. The effect of sterols and phospholipid composition,. Biochim. Biophys. Acta 1108 (1992) 49-58
270. In: Merz K., and Roux B. (Eds). Biological Membranes. A Molecular Perspective from Computation and Experiment (1996), Birkhauser, Boston
271. Merz K.M. Molecular dynamics simulations of lipid bilayers. Curr. Opin. Struct. Biol. 7 (1997) 511-517
272. Forrest L.R., and Sansom M.S.P. Membrane simulations: bigger and better?. Curr. Opin. Struct. Biol. 10 (2000) 174-181
273. Feller S.E. Molecular dynamics simulations of lipid bilayers. Curr. Opin. Coll. Interfac. Sci. 5 (2000) 217-223
274. Scott H.L. Modeling the lipid component of membranes. Curr. Opin. Struct. Biol. 12 (2002) 495-502
275. Tieleman D.P., Marrink S.J., and Berendsen H.J.C. A computer perspective of membranes: molecular dynamics studies of lipid bilayer systems. Biochim. Biophys. Acta 1331 (1997) 235-270
276. Heimburg T. Monte Carlo simulations of lipid bilayers and lipid protein interactions in the light of recent experiments. Curr. Opin. Coll. Interfac. Sci. 5 (2000) 224-231
277. Bassolinoklimas D., Alper H.E., and Stouch T.R. Solute diffusion in lipid bilayer membranes - an atomic level study by molecular dynamics simulation. Biochemistry 32 (1993) 12624-12637
278. Huang P., Bertaccini E., and Loew G.H. Molecular dynamics simulation of anesthetic-phospholipid bilayer interactions. J. Biomol. Struct. Dyn. 12 (1995) 725-754
279. Jin B., and Hopfinger A.J. Characterization of lipid membrane dynamics by simulation. 3. Probing molecular transport across the phospholipid bilayer. Pharmaceut. Res. 13 (1996) 1786-1794
280. Cascales J.J.L., Cifre J.G.H., and Delatorre J.G. Anaesthetic mechanism on a model biological membrane: a molecular dynamics simulation study. J. Phys. Chem. B 102 (1998) 625-631
281. Fernandes M.X., Huertas M.L., Castanho M.A.R.B., and Delatorre J.G. Simulation of the distribution and diffusion of a rigid amphipathic particle embedded in a model membrane. Biophys. Chem. 79 (1999) 41-53
282. Pasenkiewicz-Gierula M., Rog T., Grochowski J., Serda P., Czarnecki R., Librowski T., and Lochynski S. Effects of a carane derivative local anesthetic on a phospholipid bilayer studied by molecular dynamics simulation. Biophys. J. 85 (2003) 1248-1258
283. Sansom M.S.P., Tieleman D.P., Forrest L.R., and Berendsen H.J.C. Molecular dynamics simulations of membranes with embedded proteins and peptides: porin, alamethicin and influenza virus M2. Biochem. Soc. Trans. 26 (1998) 438-443
284. Im W., Seefeld S., and Roux B. A grand canonical Monte Carlo-Brownian dynamics algorithm for simulating ion channels. Biophys. J. 79 (2000) 788-801
285. Im W., and Roux B. Brownian dynamics simulations of ions channels: a general treatment of electrostatic reaction fields for molecular pores of arbitrary geometry. J. Chem. Phys. 115 (2001) 4850-4861
286. Sansom M.S.P., Shrivastava I.H., Bright J.N., Tate J., Capener C.E., and Biggin P.C. Potassium channels: structures, models, simulations. Biochim. Biophys. Acta 1565 (2002) 294-307
287. Roux B. Theoretical and computational models of ion channels. Curr. Opin. Struct. Biol. 12 (2002) 182-189
288. Fischer W.B., and Sansom M.S.P. Viral ion channels: structure and function. Biochim. Biophys. Acta 1561 (2002) 27-45
289. Capener C.E., Kim H.J., Arinaminpathy Y., and Sansom M.S.P. Ion channels: structural bioinformatics and modelling. Hum. Mol. Genet. 11 (2002) 2425-2433
290. Miyashita O., Onuchic J.N., and Okamura M.Y. Continuum electrostatic model for the binding of cytochrome c(2) to the photosynthetic reaction center from Rhodobacter sphaeroides. Biochemistry 42 (2003) 11651-11660
291. Peitzsch R.M., Eisenberg M., Sharp K.A., and Mclaughlin S. Calculations of the electrostatic potential adjacent to model phospholipid bilayers. Biophys. J. 68 (1995) 729-738
292. Tobias D.J. Electrostatics calculations: recent methodological advances and applications to membranes. Curr. Opin. Struct. Biol. 11 (2001) 253-261
293. Lin J.H., Baker N.A., and McCammon J.A. Bridging implicit and explicit solvent approaches for membrane electrostatics. Biophys. J. 83 (2002) 1374-1379
294. BenTal N., Honig B., Miller C., and Mclaughlin S. Electrostatic binding of proteins to membranes. Theoretical predictions and experimental results with charybdotoxin and phospholipid vesicles,. Biophys. J. 73 (1997) 1717-1727
295. Kessel A., Musafia B., and BenTal N. Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer. Biophys. J. 80 (2001) 2536-2545
296. Cheng W., Wang C.X., Chen W.Z., Xu Y.W., and Shi Y.Y. Investigating the dielectric effects of channel pore water on the electrostatic barriers of the permeation ion by the finite difference Poisson-Boltzmann method. Eur. Biophys. J. Biophys. Lett. 27 (1998) 105-112
297. Moy G., Corry B., Kuyucak S., and Chung S.H. Tests of continuum theories as models of ion channels. I. Poisson-Boltzmann theory versus Brownian dynamics,. Biophys. J. 78 (2000) 2349-2363
298. Im W., and Roux B. Ion permeation and selectivity of OmpF porin: a theoretical study based on molecular dynamics, Brownian dynamics, and continuum electrodiffusion theory. J. Mol. Biol. 322 (2002) 851-869
299. + channel. Proc. Nat. Acad. Sci. USA 100 (2003) 8644-8648
300. Moore P.B., Lopez C.F., and Klein M.L. Dynamical properties of a hydrated lipid bilayer from a multinanosecond molecular dynamics simulation. Biophys. J. 81 (2001) 2484-2494
301. Pastor R.W., Venable R.M., and Feller S.E. Lipid bilayers, NMR relaxation, and computer simulations. Account. Chem. Res. 35 (2002) 438-446
302. Anezo C., Devries A.H., Holtje H.D., Tieleman D.P., and Marrink S.J. Methodological issues in lipid bilayer simulations. J. Phys. Chem. B 107 (2003) 9424-9433
303. Schlenkrich M., Brickmann J., Mackerell A.D., and Karplus M. An empirical potential energy function for phospholipids: criteria for parameter optimization and applications. In: Merz K., and Roux B. (Eds). Biological Membranes. A Molecular Perspective from Computation and Experiment (1996), Birkhauser, Boston 31-81
304. Sintes T., Baumgartner A., and Levine Y.K. Coarse-grained continuum model for molecular diffusion in a lipid monolayer. J. Mol. Liq. 84 (2000) 77-88
305. Lopez C.F., Moore P.B., Shelley J.C., Shelley M.Y., and Klein M.L. Computer simulation studies of biomembranes using a coarse grain model. Comput. Phys. Commun. 147 (2002) 1-6
306. Saiz L., and Klein M.L. Computer simulation studies of model biological membranes. Account. Chem. Res. 35 (2002) 482-489
307. Damodaran K.V., and Merz K.M. Computer simulation of lipid systems. In: Lipkowitz K.B., and Boyd D.B. (Eds). Reviews in Computational Chemistry Vol. V (1994), VCH Publishers, New York 269-298
308. Saiz L., and Klein M.L. Structural properties of a highly polyunsaturated lipid bilayer from molecular dynamics simulations. Biophys. J. 81 (2001) 204-216
309. Pandit S.A., Bostick D., and Berkowitz M.L. Mixed bilayer containing dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylserine: lipid complexation, ion binding. and electrostatics, Biophys. J. 85 (2003) 3120-3131
310. Robinson A.J., Richards W.G., Thomas P.J., and Hann M.M. Behavior of cholesterol and its effect on head group and chain conformations in lipid bilayers: a molecular dynamics study. Biophys. J. 68 (1995) 164-170
311. Gabdoulline R.R., Vanderkooi G., and Zheng C. Comparison of the structures of dimyristoylphosphatidylcholine in the presence and absence of cholesterol by molecular dynamics simulations. J. Phys. Chem. 100 (1996) 15942-15946
312. Tu K.C., Klein M.L., and Tobias D.J. Constant-pressure molecular dynamics investigation of cholesterol effects in a dipalmitoylphosphatidylcholine bilayer. Biophys. J. 75 (1998) 2147-2156
313. Smondyrev A.M., and Berkowitz M.L. Structure of dipalmitoylphosphatidylcholine/cholesterol bilayer at low and high cholesterol concentrations: molecular dynamics simulation. Biophys. J. 77 (1999) 2075-2089
314. Pasenkiewicz-Gierula M., Rog T., Kitamura K., and Kusumi A. Cholesterol effects on the phosphatidylcholine bilayer polar region: a molecular simulation study. Biophys. J. 78 (2000) 1376-1389
315. Smondyrev A.M., and Berkowitz M.L. Molecular dynamics simulation of the structure of dimyristoylphosphatidylcholine bilayers with cholesterol, ergosterol, and lanosterol. Biophys. J. 80 (2001) 1649-1658
316. Rog T., and Pasenkiewicz-Gierula M. Cholesterol effects on the phosphatidylcholine bilayer nonpolar region: a molecular simulation study. Biophys. J. 81 (2001) 2190-2202
317. Rog T., and Pasenkiewicz-Gierula M. Cholesterol effects on the phospholipid condensation and packing in the bilayer: a molecular simulation study. FEBS Lett. 502 (2001) 68-71
318. Chiu S.W., Jakobsson E., and Scott H.L. Combined Monte Carlo and molecular dynamics simulation of hydrated dipalmitoyl-phosphatidylcholine-cholesterol lipid bilayers. J. Chem. Phys. 114 (2001) 5435-5443
319. Chiu S.W., Jakobsson E., Mashl R.J., and Scott H.L. Cholesterol-induced modifications in lipid bilayers: a simulation study. Biophys. J. 83 (2002) 1842-1853
320. Rog T., and Pasenkiewicz-Gierula M. Effects of epicholesterol on the phosphatidylcholine bilayer: a molecular simulation study. Biophys. J. 84 (2003) 1818-1826
321. Smondyrev A.M., and Berkowitz M.L. United atom force field for phospholipid membranes: constant pressure molecular dynamics simulation of dipalmitoylphosphatidicholine/water system. J. Comput. Chem. 20 (1999) 531-545
322. Dolan E.A., Venable R.M., Pastor R.W., and Brooks B.R. Simulations of membranes and other interfacial systems using P2(1) and pc periodic boundary conditions. Biophys. J. 82 (2002) 2317-2325
323. Anachi R.B., Bansal M., Easwaran K.R.K., Namboodri K., and Gaber B.P. Molecular modeling studies on amphotericin B and its complex with phospholipid. J. Biomol. Struct. Dyn. 12 (1995) 957-970
324. Baginski M., Gariboldi P., and Borowski E. The role of amphotericin B amine group basicity in its antifungal action - a theoretical approach. Biophys. Chem. 49 (1994) 241-250
325. Langlet J., Berges J., Caillet J., and Demaret J.P. Theoretical study of the complexation of amphotericin B with sterols. Biochim. Biophys. Acta 1191 (1994) 79-93
326. Baran M., and Mazerski J. Molecular modelling of amphotericin B-ergosterol primary complex in water. Biophys. Chem. 95 (2002) 125-133
327. Ermishkin L.N., Kasumov K.M., and Potseluyev V.M. Properties of amphotericin B channels in a lipid bilayer. Biochim. Biophys. Acta 470 (1977) 357-367
328. J. Czub, M. Baginski, Interaction of amphotericin B with phospholipids in the model membrane - molecular dynamics study, Biophys. J. 86 (1) (2004) 2163-Pos.
329. Zubrzycki I.Z., Xu Y., Madrid M., and Tang P. Molecular dynamics simulations of a fully hydrated dimyristoylphosphatidylcholine membrane in liquid-crystalline phase. J. Chem. Phys. 112 (2000) 3437-3441
330. Sternal K., Czub J., and Baginski M. Molecular aspects of the interaction between amphotericin B and a phospholipid bilayer: molecular dynamics studies. J. Mol. Model. 10 (2004) 223-232
331. Herec M., Dziubinska H., Trebacz K., Morzycki J., and Gruszecki W.I. An effect of antibiotic Amphotericin B on ion transport across model lipid membranes and tonoplast membranes. Biochem. Pharmacol. 70 (2005) 668-675